 |
|
First Parkinson's Gene Therapy Patient Passes One Year
September 02, 2004The first ever patient to have undergone gene therapy for Parkinson's appears to have come through phase I without a hitch, suggesting that the therapy is safe and effective, reports Marina Murphy in Chemistry & Industry.
'We have yet to analyse efficacy data, with the seventh of the planned twelve subjects only just having undergone gene transfer. . . But there have been no adverse effects related to the gene therapy so far,' said lead researcher Matthew During, of the University of Auckland. He continues, 'Our therapy is extremely safe and we hope there will be some symptomatic improvement.'
It is just over a year since the first patient, Nathan Klein, had a virus carrying a gene injected in a part of his brain. He claims to have experienced an improvement of 40-60% in overall symptoms when he is on his medication, and a 10-20% improvement when he is not. Prior to the surgery, he habitually suffered from a tremor on his right side.
Roger Barker, a Parkinson's expert at the University of Cambridge, who was critical of the decision to go ahead with the trial, said the fact that there has been no adverse effects is good news, but because the patient is on low doses of his medication, it is not possible to determine whether the gene therapy is any better than a more aggressive drug regime, or subthalamic nucleus (STN) deep brain stimulation.
The treatment uses a harmless virus to introduce a gene into a part of the brain that is overactive in Parkinson's patients, causing jerky movements. Introducing this gene leads to the production natural chemicals that inhibit the overactive brain cells. During's group is the only one conducting human gene therapy trials in Parkinson's and experts think that gene therapy is 20 years ahead of stem-cell therapy for Parkinson's disease.
Phase II should start at the beginning of 2005.
Society of Chemical Industry
Roger Barker, a Parkinson's expert at the University of Cambridge, who was critical of the decision to go ahead with the trial, said the fact that there has been no adverse effects is good news, but because the patient is on low doses of his medication, it is not possible to determine whether the gene therapy is any better than a more aggressive drug regime, or subthalamic nucleus (STN) deep brain stimulation.
The treatment uses a harmless virus to introduce a gene into a part of the brain that is overactive in Parkinson's patients, causing jerky movements. Introducing this gene leads to the production natural chemicals that inhibit the overactive brain cells. During's group is the only one conducting human gene therapy trials in Parkinson's and experts think that gene therapy is 20 years ahead of stem-cell therapy for Parkinson's disease.
Phase II should start at the beginning of 2005.
Society of Chemical Industry
Gene Therapy Current Events and Gene Therapy News RSSPlant polymerases IV and V are special forms of Polymerase II
It's a little like finding out that Superman is actually Clark Kent. A team of biologists at Washington University in St. Louis has discovered that two vital cellular components, nuclear RNA Polymerases IV and V (Pol IV and V), found only in plants, are actually specialized forms of RNA Polymerase II, an essential enzyme of all eukaryotic organisms, including humans.
Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
MU Researcher Refining Synthetic Molecules to Prevent HIV Resistance
Evolving HIV viral strains and the adverse side effects associated with long-term exposure to current treatments propel scientists to continue exploring alternative HIV treatments.
Researchers identify new anti-tumor gene
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers. The discovery could one day lead to an effective gene therapy for cancer.
Gene therapy effective treatment against gum disease
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
UC Davis researchers exploring gene therapy to fight AIDS
The apparent success of a case in which German doctors cured a man of AIDS using a bone marrow transplant comes as no surprise to Gerhard Bauer, a UC Davis stem cell researcher.
Gene therapy corrects sickle cell disease in laboratory study
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology.
Science teams at Cold Spring Harbor Laboratory identify 13 new tumor-suppressor genes in liver cancer
Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise. At Cold Spring Harbor Laboratory (CSHL), five different research groups have now combined their expertise to speed up the rate of discovering cancer-related genes and validating their function in living animals.
New gene silencing pathway found in plants
Biologists at Washington University in St. Louis have made major headway in explaining a mechanism by which plant cells silence potentially harmful genes.
First trial of gene therapy for advanced heart failure shows promising results
Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity.
More Gene Therapy Current Events and Gene Therapy News Articles
 | Gene Therapy for Cancer (Cancer Drug Discovery and Development) The possibility of treating cancer, a disease frequently defined bygenetic defects, by introducing genes that target these veryalterations has generated tremendous enthusiasm. This enthusiasm,however, has been tempered by an increasing number of obstacles tosuccessful therapy, including vector systems that do not reach systemicmetastases, therapeutic genes with redundant mechanisms allowing... |
 | Stem Cell and Gene-Based Therapy: Frontiers in Regenerative Medicine The inability of the human body to be able significantly to self repair injured organs and tissues results in a considerable medical and social problem. During the last few years there has been incredible progress, and the achievements in experimental strategies for tissue regeneration, particularly in cell transplantation and stem cell research, have led to potential treatment options for many... |
 | Gene Therapy and Gene Delivery Systems (Advances in Biochemical Engineering / Biotechnology) |
 | Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Third Edition This latest edition of Gene and Cell Therapy provides comprehensive coverage of all aspects of the tools and state-of-the-art technologies that are currently available in this field. Written by international leaders, this third edition features 12 additional chapters that address such new topics as gene and cell therapies for diabetes and cardiovascular disease, relevant nanotechnologies, siRNA... |
 | Gene Therapy (Special Topics in Biology Series) by Mary Colavito, Michael A. Palladino KEY MESSSAGE: Will gene therapy one day become the ultimate application of genetic technology? Gene Therapy, the newest booklet in the Special Topics in Biology Series, addresses this question by exploring gene therapy as a complex technology for delivering therapeutic genes as a way to treat and cure human genetic diseases. Author Mary Colavito provides an overview of the basic science... |
| Gene Therapy of Cancer: Methods and Protocols (Methods in Molecular Biology) Despite various difficulties, the field of gene therapy, particularly with regard to cancer, has accumulated a tremendous amount of vital pre-clinical and clinical data. "Gene Therapy of Cancer: Methods and Protocols, Second Edition" fully updates the first edition with expert coverage of established and novel protocols involving both experimental and clinical approaches to cancer gene therapy.... | |
 | Gene Therapy: Treating Disease by Repairing Genes (New Biology) by Joseph, Ph.D. Panno Many diseases are caused by a simple point mutation - they are the result of a single defective gene. Gene therapy is the attempt to replace a defective gene with a good copy or to add a good gene to compensate for the bad. Although this procedure has proven to be extremely hazardous, of all the technologies provided by the new biology, gene therapy holds much potential for curing disease.... |
 | Nonviral Vectors for Gene Therapy, Part 2, Volume 54, Second Edition (Advances in Genetics) The field of non-viral vector research has rapidly progressed since the publication of the first edition. This new edition is expanded to two separate volumes that contain in-depth discussions of different non-viral approaches, including cationic liposomes and polymers, naked DNA and various physical methods of delivery, as well as a comprehensive coverage of the molecular biological designs of... |
 | Gene Therapy Protocols: Volume 1: Production and In Vivo Applications of Gene Transfer Vectors (Methods in Molecular Biology) In Gene Therapy Protocols, Volumes 1 & 2, internationally recognized investigators describe cutting-edge laboratory techniques for the study of Production and In Vivo Applications of Gene Transfer Vectors (Volume 1) and Design and Characterization of Gene Transfer Vectors (Volume 2). The field of gene therapy has undergone remarkable advances, promising to impact human healthcare significantly in... |
 | Viral Vectors for Gene Therapy: Methods and Protocols (Methods in Molecular Medicine) Oregon Health & Science Univ., Portland, OR. Text provides basic tools needed for design targeted gene delivery vectors, and an understanding of how to apply viral vectors to the treatment of genetic disorders. Includes step-by-step methods, vectors from major categories, guidance on the selection, and examples. DNLM: Genetic... |
| © 2009 BrightSurf.com |